glp-1 colorectal cancer mortality study november 2025 Early-onset as an emerging disease of metabolic dysregulation Oncology Letters

Their weight loss solutions have completely transformed my life

Use code PCOS20 for a discount

Varenicline: mode of action, efficacy, safety and accumulated experience salient for clinical populations

The Citi Researchs Innovation Lab survey shows that users of GLP-1 for weight-loss saw a weight reduction of ~10%, compared to an average ~9% weight-loss for consumers under other weight-loss regimens

Novo is also facing legal flak from investors

By improving sleep quality and reducing daytime sleepiness, these treatments can be inferred to enhance cognitive functions, such as memory and attention, leading to improved performance at work and a reduced risk of accidents